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ABSTRACT 
The new complex of Pt(II) with camphor 4-methyl thiosemicarbazone was synthesized and 
characterized by means of MS, 
1
H-NMR and IR spectroscopes. Results show that, the molecular 
formula of new Pt(II) complex is [Pt(C12H20N3S))2]. The Pt(II) complex is of four coordinate. 
The result of in vitro anti-cancer activity of the complex has shown that the complex of Pt(II) 
with camphor 4-methyl thiosemicarbazone exhibit inhibitor on Hep-G2 and RD cancer cells 
with IC50 values of 7.74 and 7.61 µg.mL
-1
. These results indicated a potential of new 
Pt(II)complex in biomedical application. 
Keywords: camphor 4-methyl thiosemicarbazone,  complex of Pt(II). 
1. INTRODUCTION 
The anticancer drugs base on Platinum complexes are the mainstay of chemotherapy 
regimens in clinic. However, the efficacy of platinum drugs is badly affected by systemic 
toxicities and drug resistance, and the pharmacokinetics of most platinum drugs is largely 
unknown [1, 2, 3]. In recent years, platinum complexes with bioactive molecules, natural 
compounds, targeting groups or nonmaterial’s has been interested by chemical and biomedical 
researchers [4, 5, 6]. The motivation comes from some of the following demands: improve the 
selectivity or minimize the systemic toxicity of the drugs, enhance the cellular accumulation of 
the drugs, overcome the tumor resistance to the drugs, visualize the drug molecules in vitro or in 
vivo, achieve a synergistic anticancer effect between different therapeutic modalities, or to add 
extra functionality to the drugs [5, 6]. The development of drug delivery systems in the last 
several decades has provided a variety of methods including the synthesis new Pt(II), Pt(IV) 
complexes,  the incorporation of drugs into liposome’s, lipid emulsions, and polymeric micelles 
to reduce side effects, to increase their solubility, and to prolong circulation time as well [6]. 
Camphor has bioactivity, it has been used in traditional medicine from time immemorial. The 
coordination of camphor and platinum could create new compounds with high bioactivity. In 
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this paper, we present the new results of Pt(II) complex with camphor 4-methyl 
thiosemicarbazone.  
2. CHEMICALS AND METHODS 
2.1. Chemicals 
Camphor, 4-methyl thiosemicarbazide, acetic acid and ethanol were purchased from Merck, 
K2[PtCl4] was purchased from Sigma - Aldrich. 
2.2. Methods 
2.2.1. Synthesis of camphor 4-methyl thiosemicarbazone (H4methiocam) 
The H4methiocam was prepared from 4-methyl thiosemicarbazide and camphor (1:1 molar 
ratio). The mixture of reactants (2.1 g, 20 mmol 4-methyl thiosemicarbazide and 3.04 g, 20 
mmol camphor) was dissolved in warm ethanol – water solvent (120 mL ethanol and 80 mL 
water) and anhydrous acetic acid was added until pH reached 4. This mixture was stirred and 
reflux at 70 
o
C for 6 h. After cooling to room temperature, crystalline product was isolated and 
washed with water and dried over P2O5. H4methiocam was obtained as a white powder. Yield 
(3.52g, 74 %). 
2.2.2. Synthesis of Pt(II)complex (Pt-4methiocam). 
To synthesize Pt-4methiocam, a solution of K2[PtCl4] (0.415 g, 1 mmol) in water (50 mL) 
was added to a solution of camphor 4-methyl thiosemicarbazone (0.478 g, 2 mmol) in ethanol 
(100 mL) at 30 
0
C under stirring for 1 h. The reaction mixture was kept at room temperature for 
24 h. Afterwards, the precipitate was filtered and washed several times with water and dried over 
P2O5. The Pt-4methiocam was obtained as a yellow powder. Yield (0.623 g, 93 %). 
2.2.3. Structure determination 
Mass spectroscopy with electrospray ionization technique (ESI-MS) was used in order to 
confirm the formula of new compounds (Agilent 1100 LC/MSD Trap). IR spectra were recorded 
with a FTIR Shimadzu spectrophotometer using KBr discs. 
1
H-NMR spectra were obtained with 
a Bruker 500 MHz spectrometer and the chemical shifts tare given in units  of δ relative to TMS 
as an internal standard using DMSO-d6 as the solvent. 
2.2.4. Cytotoxicity assay 
The cytotoxicity assay was performed based on the method of Skehan et al. [7] and  
Likhiwitayawuid et al. [8] using sulforhodamine B(SRB). Ellipticine was used as the positive 
reference.  
3. RESULTS AND DISCUSSION 
3.1. The result of spectra 
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Mass spectra of H4methiocam and Pt-4methiocam are shown in Fig.1, ESI/MS data in 
Table 1.  
As seen in the MS spectra (Fig. 1(a,b)), the appearance of a cluster of peaks with m/z 
(MH
+
) = 240, 241, 242 of H4methiocam (Fig. 1(a)) and a cluster of peaks with m/z = 795, 796, 
797 of Pt-4methiocam (Fig. 1(b)) were consistent with the molecular formula of ligand 
C12H21N3S and the complex Pt(C12H21N3S)2 calculated from different isotopes.  
Table 1. MS data and compound’s molecular formula. 
Sample m/z, [M+H]+ M Molecular formula 
H4methiocam 240 239 C12H21N3S 
Pt-4methiocam 672 671 Pt(C12H20N3S)2 
 
                                                                                        
Figure 1. Mass spectra of H4methiocam (a) and Pt-4methiocam (b). 
The 
1
H-NMR spectrum of H4methiocam (Fig. 2(a)) exhibited a singlet at 9.68 ppm 
attributed to NH-hydrazine proton. The presence of NH signal indicated the presence of 
H4methiocam in the thione form. The proton signal of the NH-amide appeared at 7.96 ppm.  
Signals at 1.27 ppm to 1.77 ppm  were assigned to 9H of 3 CH3 groups (of camphor) and signals 
in range 1.80 to 2.93 ppm were assigned to protons of CH and CH2. The signal at 3.33 ppm was 
assigned to 3H of CH3 (of CH3-N). The H signal of NH-hydrazine (NHC=S group) from Pt-
4thiocam complex’s spectrum (Figure 2(b)) was changed to confirm the deprotonation of the 
ligand due to coordination with Pt(II) via S and N. The signals of other protons appeared in 
similar range in ligand’s spectrum.  
The IR spectrum of H4methiocam (Fig.3a) showed absorption bands at 3448 and 3182 cm
-1 
due to stretching frequencies for NH-amide and NH-hydrazine. The band due to the –SH group 
was not observed in 2500-2600 cm
-1 
and the presence of band at 852 cm
-1 
due to ν(C=S) 
suggested the existence of thiosemicarbazone in the thione form. The absorptions band for – CN 
appeared at 1593 cm
-1
.The IR spectrum of Pt-4methiocam  (Fig. 3b) showed absorption band at 
3313 cm
-1 
due to stretching frequencies for NH-amide, while the absorption for NH at region 
3000–3200 cm-1 was absent. The ν(C=S) band at 852 cm-1 in the spectrum of the ligand shifted to 
812 cm
-1 
in the spectrum of the complex, indicated that the existence of ligand is in the thiol 
form and deprotonation on complexation and that Pt(II) coordinated with the thiolate sulfur. The 
ν(C=N) band of the thiosemicarbazone at 1533 cm-1 shifted to 1537 cm-1 in the spectrum of the 
complex, indicated the coordination of the azomethine nitrogen. This result was confirmed by 
the presence of new bands at 611 and 405 cm
-1 
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that after deprotonation the ligand coordinated with the Pt(II) via S and N. Selected IR bands for 
the ligand (H4methiocam) and complex (Pt-4methiocam) are given in Table 2. 
 
                                                                                                      
Figure 2. 
1
H-NMR spectra of H4methiocam (a) and Pt-4methiocam (b). 
     
Figure 3.
 
IR spectra of H4methiocam (a) and Pt-4methiocam (b). 
Table 2. Selected IR bands of the H4methiocam and Pt-4methiocam 
                            ν, cm-1 
Compounds 
NH CN  NN CS Pt-X 
(X= N, S) 
H4methiocam 3448,  3182 1533 1058 852 - 
Pt-4methiocam 3313 1537 1049 812 611, 405 
 
Based on the above analysis, reasonable structures of H4methiocam ligand and Pt-
4methiocam complex are depicted in Fig. 4. 
 



































The complex (Pt-4methiocam) was tested for the cytotoxic activity in order to evaluate 
inhibition on Hep-G2 and RD cell lines. The results show that the Pt-4methiocam inhibited to 
both Hep-G2 and RD cell lines with IC50 values of 7.74 and 7.61 g.mL
-1
 (Table 3).  














Elipticine (refrence) 5 0 - 0 - 
DMSO - 100 - 100 - 
Pt-4methiocam 10 0 7.74 0 7.61 
4. CONCLUSION 
In conclusion, the complex of camphor 4-methyl thiosemicarbazone with Pt(II) was 
successfully synthesized from K2[PtCl4] and camphor 4-methyl thiosemicarbazone in ethanol-
water solvent. The analysis data from MS, IR, and 
1
H-NMR spectra showed that the molecular 
formula of complex of Pt(II) with camphor 4-metyl thiosemicarbazone is [Pt(C12H20N3S)2]. The 
Pt(II) complex is four coordinate. The new complex displayed a high activity, it inhibits to both 
Hep-G2 and RD cancer cell lines with IC50 values of 7.74 and 7.61 µg.mL
-1
. These results 
suggest a possibility of developing Pt-4methiocam as one of the potential chemotherapeutic 
agents. 
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